Selarsdi (ustekinumab-aekn)

**Product type:** Human Prescription Drug

**Active ingredient:** USTEKINUMAB-AEKN

**Strength:** 130 mg/26mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Teva Pharmaceuticals USA, Inc.

**Marketing category:** BLA (BLA761343)

**Pharmacologic class:** Interleukin-12 Antagonist [EPC], Interleukin-12 Antagonists [MoA], Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]